Literature DB >> 29115529

Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma.

Mateusz Olbromski1, Adam Rzechonek2, Jedrzej Grzegrzolka1, Natalia Glatzel-Plucinska1, Angelika Chachaj3, Bozena Werynska4, Marzenna Podhorska-Okolow1, Piotr Dziegiel1.   

Abstract

The molecular pathogenesis of the development of non-small cell lung carcinomas (NSCLCs) is extremely complex. Understanding the molecular basis of the development of this malignant tumor may enable the use of targeted therapy, which may result in a better treatment outome for these patients. Adenocarcinoma (AC) is the most common NSCLC subtype, equally common among smokers and non-smokers, and its pathogenesis remains unknown. The SOX18 protein is an important protein that plays a role in the development of blood and lymphatic vessels during the process of embryogenesis. Recent studies have also shown that the SOX18 protein may play a significant role in tumors, including lung cancers. In the present study, we analyzed the expression of the SOX18 protein and the mRNA level in postoperative samples of AC and non-malignant lung tissues (NMLTs), and a disparity in both levels was observed. Based on our previous observations that miR-7a and miR-24-3p are able to modulate SOX18 expression in NSCLC, the main aim of this study was to verify the miRNA modulation of the SOX18 transcript with the use of the MirTrap System in established lung cancer cell lines NCI-H1703, NCI-H522 and A549. The SOX18 mRNA expression level was significantly lower in AC than that noted in the NMLTs (P<0.0001). However, the protein levels were higher in AC cases compared to levels noted in the NMLTs (P<0.0001). Additionally, correlations between the RQ values of SOX18 in NMLT and AC cases (r=0.8195, P=0.0001), and between miR-7a and miR24-3p in AC cases (r=0.4344, P=0.0016), were noted. In conclusion, we confirmed that miR-7a and miR-24-3p are more highly expressed in NMLTs than in the AC samples, and that they modulate the SOX18 transcript in NSCLC cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29115529     DOI: 10.3892/or.2017.6077

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

Review 1.  Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.

Authors:  Sanjukta Mukherjee; Bhagyashree Shelar; Sudhir Krishna
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

Review 2.  Role of the SOX18 protein in neoplastic processes.

Authors:  Mateusz Olbromski; Marzenna Podhorska-Okołów; Piotr Dzięgiel
Journal:  Oncol Lett       Date:  2018-05-25       Impact factor: 2.967

3.  Role of tesmin expression in non-small cell lung cancer.

Authors:  Jedrzej Grzegrzolka; Mateusz Olbromski; Agnieszka Gomulkiewicz; Aleksandra Piotrowska; Natalia Glatzel-Plucinska; Katarzyna Ratajczak; Patrycja Sputa-Grzegrzolka; Adam Rzechonek; Bozena Werynska; Marzena Podhorska-Okolow; Piotr Dziegiel
Journal:  Oncol Lett       Date:  2020-11-17       Impact factor: 2.967

Review 4.  The Impact of Air Pollution Exposure on the MicroRNA Machinery and Lung Cancer Development.

Authors:  Michal Sima; Andrea Rossnerova; Zuzana Simova; Pavel Rossner
Journal:  J Pers Med       Date:  2021-01-19

5.  Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma.

Authors:  Shuoze Gao; Zhiping Wang
Journal:  J Healthc Eng       Date:  2021-06-09       Impact factor: 2.682

6.  miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.

Authors:  Min Bao; Yingjian Song; Jingjing Xia; Pengling Li; Qing Liu; Zongren Wan
Journal:  Onco Targets Ther       Date:  2018-03-26       Impact factor: 4.147

7.  miR-24-3p/KLF8 Signaling Axis Contributes to LUAD Metastasis by Regulating EMT.

Authors:  Pengyu Jing; Nianlin Xie; Nan Zhao; Ximing Zhu; Pei Li; Guizhou Gao; Haizhou Dang; Zhongping Gu
Journal:  J Immunol Res       Date:  2020-04-28       Impact factor: 4.818

8.  Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.

Authors:  Xiaohui Li; Xingtao Han; Pengtao Wei; Jinhui Yang; Jiantao Sun
Journal:  Cancer Biol Ther       Date:  2020-02-23       Impact factor: 4.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.